Antibodies

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 difference

Highly effective and balanced immune response to avoid COVID-19 symptoms

A study could offer a new way to treat Type 1 and Type 2 diabetes

Spinal cord-free energy study of SARS-CoV-2 anxiety modifications

COVID-19 CG monitors local MARS-CoV-2 mutations by geographic location

Cheap mines exhibit high titers of SARS-CoV-2 antibodies in Utah

less neutralization, but still waterproof

A study shows antibody responses lasting 10 months after SARS-CoV-2 infection

BiTE Antibodies industry worldwide until 2025

Human monoclonal antibodies can be a substitute for traditional antibiotics